These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 28472610)

  • 1. Nature, functions, and clinical implications of IgG4 autoantibodies in systemic lupus erythematosus and rheumatoid arthritis.
    Pan Q; Lan Q; Peng Y; Cai J; Zheng J; Dickerson C; Xiao H; Liu HF
    Discov Med; 2017 Mar; 23(126):169-174. PubMed ID: 28472610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgG4 Autoantibodies Attenuate Systemic Lupus Erythematosus Progression by Suppressing Complement Consumption and Inflammatory Cytokine Production.
    Pan Q; Xiao H; Shi L; He Y; Cai J; Wu J; Li A; Ye L; Yang C; Liu HF
    Front Immunol; 2020; 11():1047. PubMed ID: 32625200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of IgG4 in systemic lupus erythematosus: Implications for pathogenesis and therapy.
    Liu Y; Wang Y; Hu M; Xu S; Jiang F; Han Y; Liu Z
    J Biochem Mol Toxicol; 2024 Jan; 38(1):e23626. PubMed ID: 38229315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG subclasses of antibodies to type II collagen in rheumatoid arthritis differ from those in systemic lupus erythematosus and other connective tissue diseases.
    Cook AD; Mackay IR; Cicuttini FM; Rowley MJ
    J Rheumatol; 1997 Nov; 24(11):2090-6. PubMed ID: 9375865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between IgG4 Autoantibody and Complement Abnormalities in Systemic Lupus Erythematosus.
    Pan Q; Guo L; Wu J; Cai J; Liao H; Lan Q; Peng Y; He Y; Liu HF
    Mediators Inflamm; 2016; 2016():2196986. PubMed ID: 27597802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralizing anti-IL-1 receptor antagonist autoantibodies induce inflammatory and fibrotic mediators in IgG4-related disease.
    Jarrell JA; Baker MC; Perugino CA; Liu H; Bloom MS; Maehara T; Wong HH; Lanz TV; Adamska JZ; Kongpachith S; Sokolove J; Stone JH; Pillai SS; Robinson WH
    J Allergy Clin Immunol; 2022 Jan; 149(1):358-368. PubMed ID: 33974929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of IgG subclass autoantibodies in patients with systemic lupus erythematosus and subacute cutaneous lupus erythematosus.
    Elenitsas R; Abell E; Lee YY; Huang J; Deng JS
    J Dermatol Sci; 1990 May; 1(3):207-15. PubMed ID: 2085508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Hinge Antibodies Recognize IgG Subclass- and Protease-Restricted Neoepitopes.
    Falkenburg WJ; van Schaardenburg D; Ooijevaar-de Heer P; Tsang-A-Sjoe MW; Bultink IE; Voskuyl AE; Bentlage AE; Vidarsson G; Wolbink G; Rispens T
    J Immunol; 2017 Jan; 198(1):82-93. PubMed ID: 27864476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-agalactosyl IgG antibodies and isotype profiles of rheumatoid factors in Sjögren's syndrome and rheumatoid arthritis.
    Ichikawa Y; Yamada C; Horiki T; Hoshina Y; Uchiyama M; Yamada Y; Toumatu J
    Clin Exp Rheumatol; 1998; 16(6):709-15. PubMed ID: 9844764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of IgG subclasses among human autoantibodies to Sm, RNP, dsDNA, SS-B and IgG rheumatoid factor.
    Yount WJ; Cohen P; Eisenberg RA
    Monogr Allergy; 1988; 23():41-56. PubMed ID: 2968502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody affinity and IgG subclass of responses to tetanus toxoid in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Devey ME; Bleasdale K; Isenberg DA
    Clin Exp Immunol; 1987 Jun; 68(3):562-9. PubMed ID: 3652524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG subclasses in systemic lupus erythematosus and other autoimmune rheumatic diseases.
    Blanco F; Kalsi J; Ravirajan CT; Speight P; Bradwell AR; Isenberg DA
    Lupus; 1992 Dec; 1(6):391-9. PubMed ID: 1304408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased IgG on cell-derived plasma microparticles in systemic lupus erythematosus is associated with autoantibodies and complement activation.
    Nielsen CT; Østergaard O; Stener L; Iversen LV; Truedsson L; Gullstrand B; Jacobsen S; Heegaard NH
    Arthritis Rheum; 2012 Apr; 64(4):1227-36. PubMed ID: 22238051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Catalytic autoantibodies as a new molecular instrument in rheumatological practice].
    Khitrov AN; Mal'tsev KA; Vvedenskaia OIu; Ponomarenko NA; Isaeva MA; Kimova MV; Tret'iak EB; Shogenov ZS; Alekberova ZS; Gabibov AG; Suchkov SV
    Ter Arkh; 2006; 78(6):59-66. PubMed ID: 16881365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific and shared idiotypes found on hybridoma anti-DNA autoantibodies derived from rheumatoid arthritis and systemic lupus erythematosus patients.
    Rauch J; Massicotte H; Tannenbaum H
    J Immunol; 1985 Oct; 135(4):2385-92. PubMed ID: 3875652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to the collagen-like region of C1q and type II collagen are independent non-cross-reactive populations in systemic lupus erythematosus and rheumatoid arthritis.
    Cook AD; Rowley MJ; Wines BD; Mackay IR
    J Autoimmun; 1994 Jun; 7(3):369-78. PubMed ID: 7522456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monospecific but not polyreactive human hybridoma rheumatoid factors exhibit preferential binding specificities for IgG3 and IgG4.
    Newkirk MM; Rauch J
    Rheumatol Int; 1994; 13(5):203-9. PubMed ID: 8202664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rheumatoid arthritis and systemic lupus erythematosus as immune complex diseases.
    Weissmann G
    Bull NYU Hosp Jt Dis; 2009; 67(3):251-3. PubMed ID: 19852746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical relevance of circulating immune complexes in patients with systemic lupus erythematosus and chronic polyarthritis].
    Menzel EJ; Smolen JS; Knapp W; Scherak O; Steffen C
    Acta Med Austriaca; 1979; 6(5):212-4. PubMed ID: 162334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization of an Fc-binding reactivity to the constant region of human IgG4. Implications for the pathogenesis of rheumatoid arthritis.
    Zack DJ; Stempniak M; Wong AL; Weisbart RH
    J Immunol; 1995 Nov; 155(10):5057-63. PubMed ID: 7594514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.